SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-009310
Filing Date
2019-02-21
Accepted
2019-02-21 16:18:05
Documents
1
Period of Report
2019-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv514000_4.html 4  
1 OWNERSHIP DOCUMENT tv514000_4.xml 4 5207
  Complete submission text file 0001144204-19-009310.txt   7206
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 19622091

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 19622092